Why the study?
The study was conducted to identify early pregnancy associations of congenital heart disease in a multiethnic cohort.
Are early pregnancy factors including first trimester SSRI/SNRI use, maternal mood disorders, and maternal age >40 years associated with an increased risk of congenital heart disease in offspring?
Are early pregnancy factors including first trimester SSRI/SNRI use, maternal mood disorders, and maternal age >40 years associated with an increased risk of congenital heart disease in offspring?
Answers are grounded in this paper and cite their sources.
Maternal mood disorders, first trimester SSRI/SNRI use, and maternal age >40 years are independently associated with an increased risk of congenital heart disease in offspring, whereas first trimester folate/multivitamin use is protective.
OBJECTIVE: Identify early pregnancy associations of congenital heart disease (CHD) in a multiethnic cohort. METHODS: This retrospective observational cohort study compared the general obstetric population to women who gave birth at a referral centre in Australia between 2012 and 2017, after 20 weeks' of gestation, with a pregnancy affected by CHD. We defined mood disorder and anxiety as a history of self-reported or medically diagnosed anxiety, depression, postpartum depression or bipolar disorder. RESULTS: We compared epidemiological factors between 30 842 general obstetric patients and 470 obstetric patients with a foetus affected by CHD. Multivariate analysis showed independent associations between CHD and use of selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) in the first trimester (relative risk [RR] 4.14, 95% CI 2.58-6.65), history of anxiety or mood disorder with no SSRI/SNRI first trimester (RR 2.20, 95% CI 1.77-2.74), folate and/or pregnancy multivitamin use in the first trimester (RR 0.69, 95% CI 0.55-0.87) and increased risk with maternal age >40 years (RR 2.30, 95% CI 1.57-3.38). CONCLUSIONS: Our data show maternal mood disorders with and without SSRI or SNRI use, maternal age >40 years and lack of multivitamin/folate use to be independently associated with CHD in pregnancy.
No takes yet. Share an insight, caveat, or question.
Melov et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: